Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.
about
Diabetic Macular EdemaLong-term Outcomes in Youths with Diabetes MellitusInsulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studiesProtocol for systematic review of evidence on the determinants and influence of early glycaemic control in childhood-onset type 1 diabetesDiabetic retinopathy and systemic factorsRole of mitochondria biogenesis in the metabolic memory associated with the continued progression of diabetic retinopathy and its regulation by lipoic acidDifferential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 DiabetesChanges in management and outcomes for children and adolescents with type 1 diabetes over the last 50 years.Diabetic macular edema: new concepts in patho-physiology and treatment.Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.Improving glycaemic control and life skills in adolescents with type 1 diabetes: a randomised, controlled intervention study using the Guided Self-Determination-Young method in triads of adolescents, parents and health care providers integrated intoManaging diabetic macular edema: The leading cause of diabetes blindnessTargeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria.Prevalence, Demographics, and Treatment Characteristics of Visual Impairment due to Diabetic Macular Edema in a Representative Canadian Cohort.Optimal treatment of diabetic retinopathy.A1C variability as an independent risk factor for microalbuminuria in young people with type 1 diabetes.Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy.Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDICThe prognosis of diabetic retinopathy in patients with type 2 diabetes since 1996-1998: the Skaraborg Diabetes Register.A five-year prospective study of diabetic retinopathy progression in chinese type 2 diabetes patients with "well-controlled" blood glucose.Symptoms of Eating Disorders and Depression in Emerging Adults with Early-Onset, Long-Duration Type 1 Diabetes and Their Association with Metabolic Control.Practical strategies to enhance executive functioning and strengthen diabetes management across the lifespan.INTEGRITY OF OUTER RETINAL LAYERS AFTER RESOLUTION OF CENTRAL INVOLVED DIABETIC MACULAR EDEMA.Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group.The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic RetinopathyDiabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study.Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes.HbA1c: a review of analytical and clinical aspects.Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.The Role of DNA Methylation in the Metabolic Memory Phenomenon Associated With the Continued Progression of Diabetic Retinopathy.Impact of a first-year student pharmacist diabetes self-care education program.Partnering with diabetes educators to improve patient outcomes.Microvascular disease in children and adolescents with type 1 diabetes and obesity.The path to approval of new drugs for diabetes.Hyperglycemia and vascular metabolic memory: truth or fiction?Chromium does not belong in the diabetes treatment arsenal: Current evidence and future perspectives.
P2860
Q26749438-4FE5BB77-D115-4C99-B906-56D37A820FDCQ26799531-367BBBD1-EB23-4743-AAC9-5633B46F5940Q27010850-7E3E0318-61E2-49B5-BF64-92595CFFFDD4Q28082045-33E55EAB-E7EE-4FE3-AC66-C38DD3AA809DQ28082046-37A6B622-58A3-420D-B90C-67B0A9966858Q28566371-CBE6498F-1BB3-4A9B-AF3F-B03DA0505D2DQ30300141-1B4EEFDC-6E1C-48D7-8326-54ABCFD92348Q30369998-7CCCBCED-C16C-425F-AF3B-2A2035606B59Q33713517-81954307-9826-4015-B2FE-0DC8F9B89476Q33855386-E3900B3D-778B-4E93-A60F-70A5347F629AQ33932306-6F25DE48-62B8-4139-92BB-9484E1111405Q34000861-217E7273-57A4-4DBD-8604-4A4B990A4615Q34071861-8AF91032-4124-48CB-904E-4D7074CDB38EQ34072355-611293D8-E2C0-45B9-9728-DA2719ED3A7BQ34543471-C8B564B4-5059-48B0-B318-5C7BC14797ABQ34693503-11C52E6F-759F-46E6-8A40-BAFCCDA85C2CQ34718250-C3A2A043-1645-46B1-BD76-BA8814A3EA1CQ34762475-465A4182-F741-41A5-BAF8-5028920B43E1Q34873090-AE8241C7-B93F-4C21-9E0D-1A2970751D28Q34924454-ED847FD4-B639-40AF-998A-9F6EB3D7FC2AQ35004314-F46845F4-AA87-40FD-8B06-F9C9EDE2692EQ35229103-BD934855-C5A6-4EC6-9CEB-C52BFD10816FQ35300956-326B922E-839F-48BD-9AAB-08B956AEBF02Q35677081-182FCE71-5A88-4308-8BE8-2E86CF213B01Q35845622-2D330020-D14E-4331-8E67-9D679C1DFEC6Q36250553-0CBBE84D-8C83-4024-938F-956D0D009628Q36513518-7FD35B7C-9B8D-428B-8652-11FECBCCFFD7Q36625195-5564C0DF-8A76-44F9-8FC7-C9AD92DF6993Q36629520-1107DE34-7735-46CE-A701-E0602688863FQ36772146-18A1955E-BB61-4979-90E8-A876C890C337Q37193421-08E11FB3-3AF9-4B10-BC4B-ACC54B61786BQ37284952-7BD762B6-B564-4A13-AE1E-C9B20A4C8C75Q37333543-3151580E-0E54-401F-9FAC-A6E31A01C9ECQ37384357-F4FCC97B-C32D-4584-B512-42FD141D03B4Q37414327-28A5794E-EE72-48DE-AAD8-F90872D511ABQ37589019-E7F0EBB4-905D-438C-BEDC-A6A590E89DBFQ37780987-57AC0ED2-55F8-43E0-97B4-CC5659E0C228Q38080152-CB2B7482-0539-45C8-A374-FE6CC9E7E60DQ38086111-CF4AF676-DBC9-413A-9F2D-CBCB9CECB6BEQ38205764-E4331A22-0E67-4138-B038-E2C84E09B92D
P2860
Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of prior intensive ther ...... son of adults and adolescents.
@ast
Effect of prior intensive ther ...... son of adults and adolescents.
@en
type
label
Effect of prior intensive ther ...... son of adults and adolescents.
@ast
Effect of prior intensive ther ...... son of adults and adolescents.
@en
prefLabel
Effect of prior intensive ther ...... son of adults and adolescents.
@ast
Effect of prior intensive ther ...... son of adults and adolescents.
@en
P2093
P2860
P356
P1433
P1476
Effect of prior intensive ther ...... son of adults and adolescents.
@en
P2093
DCCT-EDIC Research Group
Dean P Hainsworth
Matthew D Davis
Neil H White
Patricia A Cleary
Ronald P Danis
Wanjie Sun
P2860
P304
P356
10.2337/DB09-1216
P407
P577
2010-02-11T00:00:00Z